Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > J Korean Cancer Assoc > Volume 22(1); 1990 > Article
Original Article
COPBLAM Combination Chemotherapy in Advanced , Intermediate and High - grade Non - Hodgkin's Lymphomas
Byung Hyun Yoon, Ki Young Kwon, Hong Suck Song
Journal of the Korean Cancer Association 1990;22(1): 151-162.
  • 2,804 Views
  • 18 Download
  • 0 Crossref
  • 0 Scopus
prev next

Between June 1985 and November 1988, 30 patients with advanced stage, intermediate and high- grade non-Hodgkin's lymphoma were treated with a COPBLAM regimen including cyclophos- phamide, oncovin, prednisolone, bleomycin, adriamycin, procarbazine. Median age was 50.1 years and 10 patients were 60 years or old. 15 patients (50%) achieved a complete response (CR) and 10 patients (30%) had a partial response. Of the 15 CRs, 6 patients (40%) suffered a relapse. 3-year survival was 48.2% and disease-free survival for CRs was 54.5% with a median follow-up of 16.5 months. Constitutional symptoms were negatively associated with response rate and survival but not in disease free survival. Prognostic significance of age, histologic type, stage, and serum LDH were not demonstrated. Overall toxicity was acceptible without any treatment-related deaths. The incidenca of nonfatal infection was 16.7.

  • Cite
    CITE
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    COPBLAM Combination Chemotherapy in Advanced , Intermediate and High - grade Non - Hodgkin's Lymphomas
    J Korean Cancer Assoc. 1990;22(1):151-162.
    Close

Cancer Res Treat : Journal of the Korean Cancer Association
Close layer
TOP